login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
ATRICURE INC (ATRC) Stock News
USA
- NASDAQ:ATRC -
US04963C2098
-
Common Stock
33.12
USD
+0.22 (+0.67%)
Last: 11/17/2025, 6:04:01 PM
33.12
USD
0 (0%)
After Hours:
11/17/2025, 6:04:01 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
ATRC Latest News, Press Relases and Analysis
All
Press Releases
19 days ago - By: Chartmill
AtriCure Inc (NASDAQ:ATRC) Surpasses Q3 2025 Earnings Estimates and Raises Full-Year Outlook
10 days ago - By: Zacks Investment Research
AtriCure (ATRC) Loses 13.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
12 days ago - By: Zacks Investment Research
Here's What Key Metrics Tell Us About AtriCure (ATRC) Q3 Earnings (Revised)
13 days ago - By: Zacks Investment Research
- Mentions:
CABA
Is AtriCure (ATRC) Outperforming Other Medical Stocks This Year?
18 days ago - By: The Motley Fool
AtriCure (ATRC) Q3 2025 Earnings Call Transcript
19 days ago - By: Zacks Investment Research
Here's What Key Metrics Tell Us About AtriCure (ATRC) Q3 Earnings
19 days ago - By: Zacks Investment Research
AtriCure (ATRC) Reports Q3 Loss, Beats Revenue Estimates
19 days ago - By: AtriCure, Inc.
AtriCure Reports Third Quarter 2025 Financial Results; Raises Financial Outlook for 2025
20 days ago - By: Benzinga
- Mentions:
CGO
ROL
ESRT
NNBR
...
Earnings Scheduled For October 29, 2025
20 days ago - By: AtriCure, Inc.
AtriCure Announces the First Patient Treated in the BoxX-NoAF Clinical Trial
21 days ago - By: AtriCure, Inc.
AtriCure to Participate in Upcoming Investor Conferences
a month ago - By: AtriCure, Inc.
AtriCure to Announce Third Quarter 2025 Financial Results
2 months ago - By: AtriCure, Inc.
AtriCure Announces the Launch of the cryoXTâ„¢ Device for Post-Operative Pain Management Following Amputation
3 months ago - By: AtriCure, Inc.
AtriCure to Participate in the 2025 Wells Fargo Healthcare Conference
4 months ago - By: The Motley Fool
AtriCure (ATRC) Q2 Revenue Jumps 17%
4 months ago - By: AtriCure, Inc.
AtriCure Reports Second Quarter 2025 Financial Results; Raises Financial Outlook for 2025
4 months ago - By: AtriCure, Inc.
AtriCure to Participate in the Canaccord Genuity 45th Annual Growth Conference
4 months ago - By: AtriCure, Inc.
AtriCure Completes Enrollment in LeAAPS Clinical Trial for Stroke Prevention
4 months ago - By: AtriCure, Inc.
AtriCure to Announce Second Quarter 2025 Financial Results
6 months ago - By: Zacks Investment Research
Is Astellas Pharma (ALPMY) Stock Outpacing Its Medical Peers This Year?
6 months ago - By: AtriCure, Inc.
AtriCure to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
6 months ago - By: Zacks Investment Research
Does AtriCure (ATRC) Have the Potential to Rally 54.7% as Wall Street Analysts Expect?
7 months ago - By: Benzinga
14 Analysts Assess AtriCure: What You Need To Know
7 months ago - By: Zacks Investment Research
AtriCure (ATRC) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
7 months ago - By: Zacks Investment Research
AtriCure (ATRC) Reports Q1 Loss, Tops Revenue Estimates
7 months ago - By: Yahoo Finance
- Mentions:
PRQR
BBIO
TVGN
REGN
...
ProQR Therapeutics assumed with an Overweight at Cantor Fitzgerald
7 months ago - By: AtriCure, Inc.
AtriCure Reports First Quarter 2025 Financial Results
Please enable JavaScript to continue using this application.